GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aptevo Therapeutics APVO · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.13

-8.87%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Aptevo Therapeutics

Our reporting

Next results

1 Apr 2027

Due on 1 Apr 2027. Analysts expect earnings of -3.14 a share.

Past results

Reported against what analysts expected

14 Aug 202610 Aug 202613 May 202620 Mar 20266 Nov 202511 Aug 2025
Earnings per share-5.31-99.99-6.411684.47-40.11-151.20
Forecast-6.01-6.01-5.60-8.09-37.59-83.20

Key events

  1. 30 Dec 202518-to-1 reverse split
  2. 27 May 202520-to-1 reverse split
  3. 4 Dec 202437-to-1 reverse split
  4. 6 Mar 202444-to-1 reverse split
  5. 27 Mar 202014-to-1 reverse split
  6. 20 Jul 2016Listed

Aptevo Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.